 Pertussis vaccination is often administered via a combined DPT vaccine or, as shown here, a DTaP-IPV vaccine | |
| Vaccine description | |
|---|---|
| Target | Whooping cough |
| Vaccine type | Inactivated or subunit |
| Clinical data | |
| MedlinePlus | a682198 |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
  (what is this?) (verify) | |
Pertussis vaccine is a vaccine that protects against whooping cough (pertussis).[1][2] There are two main types: whole-cell vaccines and acellular vaccines.[1][2] The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.[1][3] The effectiveness of the vaccines appears to decrease by between 2 and 10% per year after vaccination with a more rapid decrease with the acellular vaccines.[1] The vaccine is only available in combination with tetanus and diphtheria vaccines.[1] Pertussis vaccine is estimated to have saved over 500,000 lives in 2002.[4]
- ^ a b c d e "Pertussis vaccines: WHO position paper – September 2015" (PDF). Relevé Épidémiologique Hebdomadaire. 90 (35): 433–458. August 2015. PMID 26320265. Archived from the original (PDF) on 4 March 2016.
- ^ a b "The Immunological Basis for Immunization Series: Pertussis Vaccines". World Health Organization. Archived from the original on 23 March 2018. Retrieved 22 November 2017.
- ^ Zhang L, Prietsch SO, Axelsson I, Halperin SA (September 2014). "Acellular vaccines for preventing whooping cough in children". The Cochrane Database of Systematic Reviews. 2014 (9): CD001478. doi:10.1002/14651858.CD001478.pub6. PMC 9722541. PMID 25228233.
- ^ "Annex 6 whole cell pertussis" (PDF). World Health Organization. Archived (PDF) from the original on 24 March 2012. Retrieved 5 June 2011.